Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9999 USD | +6.37% | +23.46% | +78.55% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 56.17M |
---|---|---|---|---|---|
Net income 2022 | -15M | Net income 2023 | -17M | EV / Sales 2022 | - |
Net cash position 2022 | 17.76M | Net cash position 2023 | 936K | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.95
x | P/E ratio 2023 |
-3.29
x | Employees | 9 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 32.75% |
Latest transcript on Tiziana Life Sciences Ltd
1 day | +6.37% | ||
1 week | +23.46% | ||
1 month | +50.95% | ||
3 months | +112.74% | ||
6 months | +68.05% | ||
Current year | +78.55% |
Managers | Title | Age | Since |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 20-06-30 |
Willy Simon
BRD | Director/Board Member | 72 | 15-10-31 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.9999 | +6.37% | 516,793 |
24-05-30 | 0.94 | +0.28% | 97,128 |
24-05-29 | 0.9374 | +2.00% | 137,972 |
24-05-28 | 0.919 | +13.47% | 301,464 |
24-05-24 | 0.8099 | +9.34% | 84,265 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+78.55% | 100M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- TLSA Stock